Harrington-Smith Kristen 4
4 · ImmunoGen, Inc. · Filed Nov 18, 2022
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Harrington-Smith Kristen
SVP & Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-11-15+25,000→ 25,000 total - Exercise/Conversion
Restricted Stock Unit
2022-11-15−25,000→ 50,000 totalExercise: $0.00From: 2022-11-15→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F2]The RSUs vest over a three-year period, with one-third of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.